文献速递妇科

减少子宫切除术后手术部位感染:甲硝唑联合头孢唑林与单用头孢菌素比较

Reducing surgical site infections after hysterectomy: metronidazole plus cefazolin compared with cephalosporin alone.
PubMed 文献 · Am J Obstet Gynecol · 2017-03-28

该回顾性队列研究纳入密歇根外科质量协作组2012年7月至2015年2月的18255例子宫切除术患者,比较头孢唑林联合甲硝唑与单用头孢唑林或第二代头孢菌素预防手术部位感染的效果。调整混杂因素后,联合方案的手术部位感染风险显著低于单用头孢唑林(OR 2.30,95%CI 1.06-4.99)或第二代头孢菌素(OR 2.31,95%CI 1.21-4.41)。

要点

  • 头孢唑林联合甲硝唑组手术部位感染率为1.4%(n=13),低于头孢唑林组的1.8%(n=267)和第二代头孢菌素组的2.1%(n=49)。
  • 调整后,头孢唑林组手术部位感染风险显著高于联合组(OR 2.30,95%CI 1.06-4.99)。
  • 调整后,第二代头孢菌素组手术部位感染风险显著高于联合组(OR 2.31,95%CI 1.21-4.41)。

核心结论

  • 在这个大型队列中,预防性使用头孢唑林联合甲硝唑与单用头孢唑林或第二代头孢菌素相比,子宫切除术后手术部位感染率更低。

研究设计与样本

  • 回顾性队列研究,纳入密歇根外科质量协作组2012年7月至2015年2月期间接受腹部、阴道、腹腔镜或机器人子宫切除术的年龄>18岁患者,共18255例子宫切除术。
  • 纳入患者接受的预防性抗生素方案为头孢唑林、第二代头孢菌素或头孢唑林联合甲硝唑之一。
  • 采用多因素logistic回归评估抗生素方案的独立效应,并使用倾向性评分匹配验证结果。

主要发现

  • 总体手术部位感染率为1.8%(n=329)。
  • 未调整的手术部位感染率:头孢唑林组1.8%(n=267),第二代头孢菌素组2.1%(n=49),头孢唑林联合甲硝唑组1.4%(n=13)。
  • 调整患者和手术因素后,与头孢唑林联合甲硝唑相比,头孢唑林组手术部位感染风险显著更高(OR 2.30,95%CI 1.06-4.99)。
  • 调整后,与头孢唑林联合甲硝唑相比,第二代头孢菌素组手术部位感染风险显著更高(OR 2.31,95%CI 1.21-4.41)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Organisms that are isolated from vaginal cuff infections and pelvic abscesses after hysterectomy frequently include anaerobic vaginal flora. Metronidazole has outstanding coverage against nearly all anaerobic species, which is superior to both cefazolin and second-generation cephalosporins. Cefazolin plus metronidazole has been demonstrated to reduce infectious morbidity compared with either cefazolin or second-generation cephalosporins in other clean-contaminated procedures, which include both as colorectal surgery and cesarean delivery. OBJECTIVE: The purpose of this study was to evaluate whether the combination of cefazolin plus metronidazole before hysterectomy was more effective in the prevention of surgical site infection than existing recommendations of cefazolin or second-generation cephalosporin. STUDY DESIGN: This was a retrospective cohort study of patients in the Michigan Surgical Quality Collaborative from July 2012 through February 2015. The primary outcome was surgical site infection. Patients who were >18 years old and who underwent abdominal, vaginal, laparoscopic, or robotic hysterectomy for benign or malignant indications were included if they received 1 of the following prophylactic antibiotic regimens: cefazolin, second-generation cephalosporin, or cefazolin plus metronidazole. Multivariate logistic regression modeling was performed to evaluate the independent effect of an antibiotic regimen, and propensity score matching was used to validate the findings. RESULTS: The study included 18,255 hysterectomies. The overall rate of surgical site infection was 1.8% (n=329). The unadjusted rate of surgical site infection was 1.8% (n=267) for cefazolin, 2.1% (n=49) for second-generation cephalosporin, and 1.4% (n=13) for cefazolin plus metronidazole. After adjustment for differences in patient and operative factors among the antibiotic cohorts, compared with cefazolin plus metronidazole, we found the risk of surgical site infection was significantly higher for patients who received cefazolin (odds ratio, 2.30; 95% confidence interval, 1.06-4.99) or second-generation cephalosporin (odds ratio, 2.31; 95% confidence interval, 1.21-4.41). CONCLUSION: In this large cohort, the use of prophylactic cefazolin plus metronidazole resulted in lower surgical site infection rates after hysterectomy compared with cefazolin or second-generation cephalosporin.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Till SR, Morgan DM, Bazzi AA, et al. Reducing surgical site infections after hysterectomy: metronidazole plus cefazolin compared with cephalosporin alone. Am J Obstet Gynecol. 2017. PMID: 28363438. doi:10.1016/j.ajog.2017.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。